Related Experiment Video
Updated: Sep 16, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
In Vitro Gastrointestinal Bioaccessibility of the Phenolic Fraction from Agave inaequidens Flower
Imelda N Monroy-García1, Laura Lucely González-Galván2, Catalina Leos-Rivas2
1Departamento de Ingeniería Química y Bioquímica, Tecnológico Nacional de Mexico, Instituto Tecnológico de Los Mochis, Juan de Dios Bátiz y 20 de Noviembre, Los Mochis 81259, Sinaloa, Mexico.
Abstract:
Edible flowers are gaining recognition as rich sources of nutrients and phytochemicals. In Mexico, the flower of Agave inaequidens has been traditionally consumed since pre-Hispanic times. This study investigated its nutritional profile and the in vitro gastrointestinal bioaccessibility of its phenolic fraction. During in vitro digestion (oral, gastric, and intestinal), the total phenolic content of A. inaequidens significantly decreased from 138 to 21 mg GAE/100 g DW (15.22% bioaccessibility), while total flavonoid content dropped from 8 to 4.6 mg CE/100 g DW (57.5% bioaccessibility). Consequently, antioxidant activity, assessed by ABTS, DPPH, and hemolysis inhibition assays, also declined post-digestion. Interestingly, the digestive process modulated the flower's inhibitory activity against digestive enzymes before and after in vitro digestion: α-amylase inhibition slightly decreased (IC50 1.8 to 2.1 mg/mL), but α-glucosidase (IC50 2.7 to 1.6 mg/mL) and lipase (IC50 > 3 to 1.4 mg/mL) inhibition increased. The A. inaequidens flower is a good source of fiber and low in fat. These findings underscore its potential as a functional food ingredient, offering bioaccessible phenolic compounds with antioxidant and enzyme inhibitory properties.
Related Concept Videos
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Factors Influencing Bioavailability: First-Pass Elimination

